Exelixis
EXEL
294 hedge funds and large institutions have $5.18B invested in Exelixis in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 106 increasing their positions, 93 reducing their positions, and 55 closing their positions.
133% more call options, than puts
Call options by funds: $82.8M | Put options by funds: $35.6M
14% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 93
1.94% less ownership
Funds ownership: 80.8% → 78.86% (-1.9%)
3% less funds holding
Funds holding: 302 → 294 (-8)
11% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 55
29% less capital invested
Capital invested by funds: $7.26B → $5.18B (-$2.09B)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$64.7M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$32.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$31M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.7M |
| 5 |
Jennison Associates
New York
|
+$27.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$126M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$69M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$55.4M |
| 4 |
Two Sigma Advisers
New York
|
-$51.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$39.5M |
EXEL Hedge Fund Activity: Q1 2018 in Review
294 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2018, worth a combined $5.18B — down 29% from $7.26B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of EXEL and 49 opened new positions — a net loss of 6 holders — while 93 trimmed existing stakes and 106 added.
The largest buyer was JP Morgan Chase, adding an estimated $64.7M. The largest seller was Goldman Sachs, cutting an estimated $126M.
- 294 institutional investors held Exelixis (EXEL) as of Q1 2018, down from 302 in Q4 2017.
- Funds reported $5.18B of Exelixis stock for Q1 2018, down 29% quarter-over-quarter.
- 49 funds opened new Exelixis positions in Q1 2018 and 55 closed out, a net change of -6 holders.
- The largest Exelixis buyer in Q1 2018 was JP Morgan Chase, an estimated $64.7M added.
- The largest Exelixis seller in Q1 2018 was Goldman Sachs, an estimated $126M sold.
Based on aggregated 13F filings for Q1 2018.